Literature DB >> 20454893

Differential RNA expression of KIR alleles.

Colum McErlean1, Asensio A Gonzalez, Rodat Cunningham, Ashley Meenagh, Tanya Shovlin, Derek Middleton.   

Abstract

Allelic polymorphisms dramatically influence the phenotype of human killer immunoglobulin-like receptors (KIR) by modifying their expression in cell surfaces. It is unclear though to what extent this involves transcriptional or post-transcriptional mechanisms, as quantitative RNA expression of KIR alleles has not been systematically compared. We measured RNA transcript abundance of common KIR alleles by real-time quantitative reverse transcriptase PCR (RT-PCR) in 85 PBL samples that were allele-typed in parallel. Allele type showed little influence on transcript abundance for a given KIR gene, except for: (1) KIR2DL5B*002, which consistently showed undetectable transcripts levels; (2) truncated KIR2DS4 alleles, associated with lowered expression levels; and (3) alleles of KIR2DL4 with a single-base deletion, associated with higher expression than average. Lowered levels of truncated KIR2DS4 transcripts were confirmed by dot blot of RT-PCR products, indicating imbalanced allelic RNA expression in heterozygote genotypes containing these alleles. Imbalanced expression of truncated KIR2DS4 alleles was corroborated in family samples. Gene copy number of KIR2DL1, KIR2DL3 and KIR3DL1 influenced RNA expression, genotypes with a single copy expressing on average lower transcript amounts than those with two copies. The data show that for a given KIR gene, the common allele types found in our population express comparable RNA levels, except truncated or null alleles. Thus, variation of KIR expression on cell surfaces more likely involves post-transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454893     DOI: 10.1007/s00251-010-0449-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  50 in total

Review 1.  Nonsense-mediated mRNA decay: terminating erroneous gene expression.

Authors:  Kristian E Baker; Roy Parker
Journal:  Curr Opin Cell Biol       Date:  2004-06       Impact factor: 8.382

2.  NK cells--from basic research to cancer therapy.

Authors:  Adelheid Cerwenka; Christine S Falk; Carsten Watzl
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

3.  Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

Authors:  Tiernan J Mulrooney; LiHua Hou; Noriko K Steiner; Minghua Chen; Ian Belle; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

4.  Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Authors:  Rasmi Thomas; Eriko Yamada; Galit Alter; Maureen P Martin; Arman A Bashirova; Paul J Norman; Marcus Altfeld; Peter Parham; Stephen K Anderson; Daniel W McVicar; Mary Carrington
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.

Authors:  Laure Denis; Katia Gagne; Brigitte Gueglio; Nolwenn Kerdudou; Noel Milpied; Philippe Simon; Gilles Follea; Marc Bonneville; Jean-Luc Harousseau; Jean-Denis Bignon
Journal:  Hum Immunol       Date:  2005-02-19       Impact factor: 2.850

6.  Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations.

Authors:  Derek Middleton; Asensio Gonzalez; Paula M Gilmore
Journal:  Hum Immunol       Date:  2007-01-05       Impact factor: 2.850

7.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Noriko Shimasaki; Chihaya Imai; Jing Ma; Timothy Lockey; Paul Eldridge; Wing H Leung; Dario Campana
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

Review 8.  Killer cell immunoglobulin-like receptors on NK cells: the how, where and why.

Authors:  Clair M Gardiner
Journal:  Int J Immunogenet       Date:  2007-12-18       Impact factor: 1.466

9.  Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule.

Authors:  C J VandenBussche; T J Mulrooney; W R Frazier; S Dakshanamurthy; C K Hurley
Journal:  Genes Immun       Date:  2008-11-13       Impact factor: 2.676

Review 10.  Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

Authors:  Jason D Barbour; Uma Sriram; Stacy J Caillier; Jay A Levy; Frederick M Hecht; Jorge R Oksenberg
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

View more
  11 in total

1.  KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population.

Authors:  S D Tao; Y M He; Y L Ying; J He; F M Zhu; H J Lv
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

2.  A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs.

Authors:  K Czaja; A-S Borer; L Schmied; G Terszowski; M Stern; A Gonzalez
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

3.  Influence of KIR gene copy number on natural killer cell education.

Authors:  Vivien Béziat; James A Traherne; Lisa L Liu; Jyothi Jayaraman; Monika Enqvist; Stella Larsson; John Trowsdale; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

4.  Characterization of killer immunoglobulin-like receptor genetics and comprehensive genotyping by pyrosequencing in rhesus macaques.

Authors:  Anna J Moreland; Lisbeth A Guethlein; R Keith Reeves; Karl W Broman; R Paul Johnson; Peter Parham; David H O'Connor; Benjamin N Bimber
Journal:  BMC Genomics       Date:  2011-06-07       Impact factor: 3.969

5.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

6.  NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.

Authors:  Erin M Sullivan; Sima Jeha; Guolian Kang; Cheng Cheng; Barbara Rooney; Martha Holladay; Rafijul Bari; Sarah Schell; MaCal Tuggle; Ching-Hon Pui; Wing Leung
Journal:  Clin Cancer Res       Date:  2014-10-03       Impact factor: 12.531

7.  KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function.

Authors:  Aimee M Merino; Anne-Sophie Dugast; Craig M Wilson; Paul A Goepfert; Galit Alter; Richard A Kaslow; Jianming Tang
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  High-Resolution Genetic and Phenotypic Analysis of KIR2DL1 Alleles and Their Association with Pre-Eclampsia.

Authors:  Oisín Huhn; Olympe Chazara; Martin A Ivarsson; Christelle Retière; Timothy C Venkatesan; Paul J Norman; Hugo G Hilton; Jyothi Jayaraman; James A Traherne; John Trowsdale; Mitsutero Ito; Christiane Kling; Peter Parham; Hormas Ghadially; Ashley Moffett; Andrew M Sharkey; Francesco Colucci
Journal:  J Immunol       Date:  2018-09-24       Impact factor: 5.422

9.  Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans.

Authors:  Sanne Vendelbosch; Martin de Boer; Remko A T W Gouw; Cynthia K Y Ho; Judy Geissler; Wendy T N Swelsen; Michael J Moorhouse; Neubury M Lardy; Dirk Roos; Timo K van den Berg; Taco W Kuijpers
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.

Authors:  Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2013-01-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.